Carlo Alberto Giorgi

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Valentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni et al. · Annals of Oncology · 2019 · 93 citations · Full text

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy

Maria Vittoria Dieci, Gaia Griguolo, Michele Bottosso et al. · npj Breast Cancer · 2021 · 93 citations · Full text

Immune characterization of breast cancer metastases: prognostic implications

Maria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto et al. · Breast Cancer Research · 2018 · 85 citations · Full text

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease

Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo et al. · Frontiers in Oncology · 2019 · 68 citations · Full text

Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy

Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo et al. · European Journal of Cancer · 2020 · 68 citations · Full text